Fusion gene information | Fusion gene name: ITPA-HLA-B |
Fusion gene ID: hg3704tg3106 | | Hgene | Tgene | Gene symbol | ITPA | HLA-B | Gene ID | 3704 | 3106 | Gene name | inosine triphosphatase | major histocompatibility complex, class I, B |
Synonyms | C20orf37|HLC14-06-P|ITPase|My049|NTPase|dJ794I6.3 | AS|B-4901|HLAB |
Cytomap | ('ITPA')('HLA-B') 20p13 | 6p21.33 |
Type of gene | protein-coding | protein-coding |
Description | inosine triphosphate pyrophosphataseepididymis secretory sperm binding proteininosine triphosphatase (nucleoside triphosphate pyrophosphatase)inosine triphosphate pyrophosphohydrolasenon-canonical purine NTP pyrophosphatasenon-standard purine NTP pyr | major histocompatibility complex, class I, BHLA class I antigen HLA-BHLA class I histocompatibility antigen, B alpha chainMHC HLA-B cell surface glycoproteinMHC HLA-B transmembrane glycoproteinMHC class 1 antigenMHC class I antigen HLA-B alpha chain |
Modification date | 20200320 | 20200322 |
UniProtAcc | . | . |
Ensembl transtripts involved in fusion gene | ENST00000380113, ENST00000399838, ENST00000455664, ENST00000483354,
| |
Fusion gene scores | * DoF score | 4 X 4 X 2=32 | 7 X 10 X 1=70 |
# samples | 4 | 10 |
** MAII score | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(10/70*10)=0.514573172829758 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 |
Context | PubMed: ITPA [Title/Abstract] AND HLA-B [Title/Abstract] AND fusion [Title/Abstract] |
Most frequent breakpoint | ITPA(3202887)-HLA-B(31321654), # samples:1
|
Anticipated loss of major functional domain due to fusion event. | |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ITPA | C0342800 | Inosine Triphosphatase Deficiency | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | ITPA | C4225256 | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35 | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | ITPA | C0025521 | Inborn Errors of Metabolism | 2 | CTD_human |
Hgene | ITPA | C0002878 | Anemia, Hemolytic | 1 | CTD_human |
Hgene | ITPA | C0002879 | Anemia, Hemolytic, Acquired | 1 | CTD_human |
Hgene | ITPA | C0002889 | Anemia, Microangiopathic | 1 | CTD_human |
Hgene | ITPA | C0040034 | Thrombocytopenia | 1 | CTD_human |
Hgene | ITPA | C0221021 | Microangiopathic hemolytic anemia | 1 | CTD_human |
Tgene | | C0014518 | Toxic Epidermal Necrolysis | 9 | CTD_human |
Tgene | | C0038325 | Stevens-Johnson Syndrome | 9 | CTD_human;ORPHANET |
Tgene | | C1274933 | Drug-Induced Stevens Johnson Syndrome | 9 | CTD_human |
Tgene | | C3658301 | Mycoplasma-Induced Stevens-Johnson Syndrome | 9 | CTD_human |
Tgene | | C3658302 | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 9 | CTD_human |
Tgene | | C0013221 | Drug toxicity | 6 | CTD_human |
Tgene | | C0041755 | Adverse reaction to drug | 6 | CTD_human |
Tgene | | C0013182 | Drug Allergy | 4 | CTD_human |
Tgene | | C0033687 | Proteinuria | 4 | CTD_human |
Tgene | | C0038013 | Ankylosing spondylitis | 3 | CTD_human |
Tgene | | C0004943 | Behcet Syndrome | 2 | CTD_human;ORPHANET |
Tgene | | C0011603 | Dermatitis | 2 | CTD_human |
Tgene | | C0011609 | Drug Eruptions | 2 | CTD_human |
Tgene | | C0026896 | Myasthenia Gravis | 2 | CTD_human |
Tgene | | C0036341 | Schizophrenia | 2 | PSYGENET |
Tgene | | C0039263 | Takayasu Arteritis | 2 | ORPHANET |
Tgene | | C0406537 | Morbilliform Drug Reaction | 2 | CTD_human |
Tgene | | C0751339 | Myasthenia Gravis, Generalized | 2 | CTD_human |
Tgene | | C0751340 | Myasthenia Gravis, Ocular | 2 | CTD_human |
Tgene | | C0011633 | Dermatomyositis | 1 | CTD_human |
Tgene | | C0015230 | Exanthema | 1 | CTD_human |
Tgene | | C0017638 | Glioma | 1 | CTD_human |
Tgene | | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Tgene | | C0019693 | HIV Infections | 1 | CTD_human |
Tgene | | C0020517 | Hypersensitivity | 1 | CTD_human |
Tgene | | C0026654 | Moyamoya Disease | 1 | GENOMICS_ENGLAND |
Tgene | | C0027697 | Nephritis | 1 | CTD_human |
Tgene | | C0033975 | Psychotic Disorders | 1 | PSYGENET |
Tgene | | C0039103 | Synovitis | 1 | CTD_human |
Tgene | | C0221056 | Adult type dermatomyositis | 1 | CTD_human |
Tgene | | C0259783 | mixed gliomas | 1 | CTD_human |
Tgene | | C0263666 | Dermatomyositis, Childhood Type | 1 | CTD_human |
Tgene | | C0410574 | Synovial Hypertrophy | 1 | CTD_human |
Tgene | | C0555198 | Malignant Glioma | 1 | CTD_human |
Tgene | | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Tgene | | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Tgene | | C1527304 | Allergic Reaction | 1 | CTD_human |
Tgene | | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Tgene | | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
Tgene | | C4505456 | HIV Coinfection | 1 | CTD_human |